Related Topics

    Ribeiro: News Releases & Feature Stories

    Genome reveals clues for better diagnosis and treatment of rare adrenal cancer

    St. Jude scientists identify key molecular events in pediatric adrenocortical tumors. The findings could help clinicians identify most malignant subtypes and lead to better treatment.

    Raul Ribeiro, M.D., honored for international work in childhood cancer research and treatment

    St. Jude Children’s Research Hospital physician receives the Paul P. Carbone Award in International Oncology from the International Network for Cancer Treatment and Research for his efforts to improve childhood cancer survival rates across the globe.

    Ellen Taylor: Beyond the yellow brick road

    One gray, winter day a cyclone picked up tiny Ellen Taylor and plopped her into an alien land. How could she muster the wisdom, the courage and the heart to travel the difficult road ahead?

    St. Jude Acute Lymphoblastic Leukemia Team recognized with prestigious science award

    Scientists at St. Jude Children’s Research Hospital who represent the interdisciplinary team studying acute lymphoblastic leukemia (ALL) have been recognized by the American Association for Cancer Research (AACR) with the AACR Team Science Award.

    Outreach through Oncopedia

    The mission of St. Jude Children’s Research Hospital extends far beyond the borders of the United States. An interactive Web site known as Oncopedia helps health care providers in the world’s most remote regions access St. Jude knowledge and research with the click of a computer mouse.

    Small investment could boost pediatric cancer survivorship in poorer nations

    A small hike in funding for pediatric cancer care could significantly boost survival rates in low- and middle-income nations, according to an international team lead by St. Jude.

    St. Jude helps Brazil improve outcomes of children with leukemia

    St. Jude has significantly reduced the rate at which families in Recife, Brazil, abandon treatment for their children who have acute lymphoblastic leukemia, and has significantly increased the rate of event-free survival during a single decade.

    Collaboration in China saves lives of children with cancer

    A small pilot program in the People's Republic of China has saved the lives of children who would otherwise have died from acute lymphoblastic leukemia (ALL) because of their family's inability to pay for care.

    St. Jude develops more affordable ALL follow-up test

    A simple new test is inexpensive enough to use routinely in institutes with limited resources; it guides fine-tuning of follow-up therapy to save more children from harsh chemotherapy and fatal infections.

    A closer look at ways to treat AML

    A review of long-term results of acute myeloid leukemia (AML) clinical trials at St. Jude suggests that the "one-size-fits-all" approach of the past 20 years should be replaced with therapies designed for specific subtypes of AML.

    Pediatric cancer lacks priority in developing countries

    Partnerships between institutions from developed and underdeveloped countries could improve treatment of children with cancer even in areas of the world that have limited resources, according to St. Jude.

    Cure4Kids reaches 100th Country has achieved a milestone reaching Cote d'Ivoire, the 100th country to join the program.

    St. Jude helps South American community improve survival rates for children with leukemia

    The city of Recife, Brazil, experienced a significant improvement in outcome among children treated for acute lymphoblastic leukemia (ALL) during the past decade, even though the community is resource-poor and most patient families are impoverished.

    Following the Clues

    Why are children in southern Brazil more susceptible to a rare type of cancer than children in other parts of the world? St. Jude researchers and clinicians spend more than a decade unraveling the mystery.